Related Experiment Video

Updated: Aug 13, 2026

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
09:16

Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants

Published on: February 21, 2015

Should we screen for congenital adrenal hyperplasia? A review of 117 cases

N K Virdi, P H Rayner, B T Rudd

    Archives of Disease in Childhood
    |July 1, 1987
    PubMed

    Insights

    Early diagnosis of congenital adrenal hyperplasia (CAH) improved after 1970 due to better testing and more specialists. Neonatal screening for CAH is not essential.

    Area of Science:

    • Pediatric Endocrinology
    • Genetics
    • Metabolic Disorders

    Background:

    • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands.
    • Early diagnosis and management are crucial for preventing life-threatening complications, particularly salt-wasting crises.

    Purpose of the Study:

    • To retrospectively analyze the diagnostic trends and outcomes of congenital adrenal hyperplasia patients.
    • To investigate factors influencing the age at diagnosis and the prevalence of salt-losing forms of CAH.

    Main Methods:

    • Retrospective review of 117 patients with CAH treated at Birmingham Children's Hospital (1958-1985).
    • Analysis of patient demographics, salt-losing status, and age at diagnosis in relation to birth year.

    Main Results:

    • The study included 47 boys and 70 girls, with 30 boys and 38 girls identified as salt losers.
    • All salt-losing CAH cases were diagnosed before 6 months of age, with 90% diagnosed within the first month.
    • Earlier diagnosis (post-1970) correlated with improved diagnostic methods (17 alpha-hydroxyprogesterone assay) and increased pediatric specialist availability.

    Conclusions:

    • Improved diagnostic capabilities and increased pediatric expertise have led to earlier identification of CAH.
    • Current diagnostic practices appear sufficient, suggesting a neonatal screening program for CAH may not be necessary.

    More Related Videos

    A Novel Method: Super-selective Adrenal Venous Sampling06:08

    A Novel Method: Super-selective Adrenal Venous Sampling

    Published on: September 15, 2017

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome08:20

    A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

    Published on: October 2, 2018

    Related Concept Videos

    Smooth Endoplasmic Reticulum01:21

    Smooth Endoplasmic Reticulum

    Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
    The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
    Cushing Syndrome I: Introduction01:26

    Cushing Syndrome I: Introduction

    Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
    Cushing Syndrome II: Pathophysiology01:19

    Cushing Syndrome II: Pathophysiology

    Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...